20 Thus, drugs utilising GIP, GLP-1, or GLP-2 receptor signalling pathways are already in clinical use, which should make potential application within the bone disease arena less complicated ( Figure 3 )
Most GLP-1 prescriptions are written by primary care physicians, endocrinologists, and telehealth providers who may have limited training in eating disorder identification
When anesthesia is administered, theres a risk of aspirationwhere stomach contents enter the lungs, potentially leading to serious complications such as pneumonia or airway obstruction
But note, not everyone experiences the large amounts of weight loss from GLP-1 RAs you may have heard about
In these patients, maintenance dosing is strongly preferred over complete discontinuation